Parenteral Nutrition Market worth over $5.7bn by 2025

Parenteral nutrition market size is set to surpass USD 5.7 billion by 2025; according to a new research study published by Global Market Insights, Inc.
 

Rising prevalence of chronic diseases such as diabetes in the past few years and increasing trends of malnutrition across the globe primarily drive the demand for various parenteral nutrition products worldwide. Additionally, growing birth rates and increasing incidence of pre-mature births should augment the market demand during the forecast timeline.

 

Request Sample Buy NowInquiry Before Buying

 

Various government regulatory bodies such as, European Society for Clinical Nutrition and Metabolism and FDA, impose strict government norms in the approval of parenteral nutrition products. As well as, Inadequate infrastructure in developing and under-developed regions acts as a growth hindering factor. Also, lack of awareness among the population of emerging markets happen to hamper adoption rate.
 

Browse key industry insights spread across 165 pages with 186 market data tables & 11 figures & charts from the report, “Parenteral Nutrition Market Size By Composition (Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals), By Consumer (Children and Newborns, Adults), By End-use (Hospitals, Clinics, Homecare) Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/parenteral-nutrition-market

 

Parenteral Nutrition Market

Get more details on this report - Request Free Sample PDF

 

Amino acid composition segment in the parenteral nutrition market accounted for 1.75 billion in 2018. Steadily growing acceptance of amino acid based parenteral nutrition products will spur the industry growth in coming years. However, due to increasing cases of renal insufficiency, hepatic insufficiency and protein-catabolic critical illness globally will boost the demand for amino acid based parenteral nutrition products. Deficiency of energy and dietary proteins are customary in critically ill hospitalized patients that ultimately leads to protein-energy malnutrition.
 

Child parenteral nutrition segment is expected to witness around 4.6% growth rate till 2025 owing to the increasing burden of genetic and neonatal diseases. Frequent rise in pediatric disorders will create mineral and vitamin deficiencies amongst children that will fuel the growth for parenteral nutrition products. Also, initiatives adopted by various organizations such as, knowledge sharing programs for individuals regarding essential nutrients necessary to infants will enhance the demand for neonatal parenteral nutrition.
 

 Parenteral nutrition market for hospitals end-use segment exceeded USD 3.15 billion in the 2018. Availability of advanced therapeutic solutions in the hospital settings will propel the demand for parenteral nutrition products. Patients suffering from critical medical conditions are mostly in treated in hospitals where they are administered parenteral care, thus presence of state of art facilities in the multi-specialty hospitals and growing popularity of hospitals in developed countries will foster the market value over the coming years.
 

The U.S. parenteral nutrition market is estimated to grow at a CAGR of 3.3% through 2025 on account of growing healthcare expenses coupled with increase in awareness amongst the population about parenteral nutrition products and rising prevalence of cardiac diseases. Improving healthcare infrastructure, developing and expanding hospital sector, and presence of major industry players such as B. Braun with rapidly expanding business led by international pediatric nutritionals will increase the regional share.
 

Some of the key players operating in the market are Aculife Healthcare, Amanta Healthcare, B. Braun Melsungen AG, Baxter International, Inc., Fresenius Kabi AG, Grifols International S.A., Guangzhou Baiyunshan Mingxing Pharmaceutical Co. Ltd., Guangzhou Green Cross Pharmaceutical Co., Ltd., and ICU Medical etc. The industry participants focus on acquisitions and mergers, new product developments and geographical expansion to increase their foothold in the market and gain competitive advantage.
 

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X